Recently, there has been great interest in metallopharmaceuticals as potential anticancer agents. In this context, presented studies aim to synthesize and evaluate of two copper(II) complexes derived from phthalazine- and imidazoline-based ligands against on three human cancer cell lines: cervix epithelial cell line (HeLa), breast epithelial-like adenocarcinoma (MCF-7), and triple–negative breast epithelial cancer cell line (MDA-MB-231), as well as non-tumorigenic cell line (HDFa). Moreover their antimicrobial, and antioxidant properties were assessed.
Authors
- dr. inż. Łukasz Balewski,
- Iwona Inkielewicz-Stępniak,
- Maria Gdaniec,
- Katarzyna Turecka,
- Anna Hering,
- dr inż. Anna Ordyszewska link open in new tab ,
- Anita Kornicka
Additional information
- DOI
- Digital Object Identifier link open in new tab 10.3390/ph18030375
- Category
- Publikacja w czasopiśmie
- Type
- artykuły w czasopismach
- Language
- angielski
- Publication year
- 2025
